US Patent Issued to Wellmarker Bio on May 19 for "Anti-IGSF1 antibody and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,629, issued on May 19, was assigned to Wellmarker Bio Co. Ltd. (Seoul, South Korea).

"Anti-IGSF1 antibody and use thereof" was invented by Seong-Rak Kim (Seoul, South Korea), Hye-Jin Son (Seoul, South Korea), Mi-So Lee (Seoul, South Korea), Ha-Na Kim (Seoul, South Korea), Jun-Hyung Lee (Seoul, South Korea) and Won-Hwa Shin (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel antibody that specifically binds to IGSF1 and a pharmaceutical composition for preventing or treating cancer, comprising the same as an active ingredient. Specifically, an antibody that binds to the C-terminus of IGSF1. Therefore, the anti-IGSF1 antibody may...